Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The Journal of Physiology|September 19, 2019
Early sinusoidal heart rate patterns and heart rate variability to assess hypoxia-ischaemia in near-term fetal sheepMichi Kasai, Christopher A Lear, Joanne O Davidson, et al.
Neuropharmacology|April 15, 2014
nNOS inhibition during profound asphyxia reduces seizure burden and improves survival of striatal phenotypic neurons in preterm fetal sheepPaul P Drury, Joanne O Davidson, Sam Mathai, et al.
The American Journal of Gastroenterology|October 29, 2000
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment GroupM L Shiffman, C M Hofmann, J Gabbay, et al.
Experimental Neurology|October 15, 2013
Partial neuroprotection by nNOS inhibition during profound asphyxia in preterm fetal sheepPaul P Drury, Joanne O Davidson, Lotte G van den Heuij, et al.
The Journal of Physiology|July 25, 2020
Peripheral chemoreflex control of fetal heart rate decelerations overwhelms the baroreflex during brief umbilical cord occlusions in fetal sheepChristopher A Lear, Michi Kasai, Lindsea C Booth, et al.
The Lancet. Respiratory Medicine|November 15, 2020
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trialPhillip D Monk, Richard J Marsden, Victoria J Tear, et al.
Lancet (London, England)|November 29, 2005
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trialA Keech, R J Simes, P Barter, et al.
ERJ Open Research|March 30, 2023
Nebulised interferon-β1a (SNG001) in hospitalised COVID-19: SPRINTER phase III studyPhillip D Monk, Jody L Brookes, Victoria J Tear, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 23, 2002
A randomized trial of sodium fluoride (60 mg) +/- estrogen in postmenopausal osteoporotic vertebral fractures: increased vertebral fractures and peripheral bone loss with sodium fluoride; concurrent estrogen prevents peripheral loss, but not vertebral fracturesD H Gutteridge, G O Stewart, R L Prince, et al.
Respiratory Research|May 29, 2024
Nebulised interferon beta-1a (SNG001) in the treatment of viral exacerbations of COPDPhillip D Monk, Jody L Brookes, Victoria J Tear, et al.
Pageof 12